Plus Therapeutics (PSTV) Misses Q2 EPS by 1c

Plus Therapeutics (NASDAQ: PSTV) reported Q2 EPS of ($0.01). Revenue for the quarter came in at $1.39 million.

For earnings history and earnings-related data on Plus Therapeutics (PSTV) click here.

You May Also Be Interested In

• SanDisk upgraded at JPMorgan after investor day; shares climb
• BofA Securities Resumes American Eagle Outfitters (AEO) at Underperform
• Applied Industrial Technologies (AIT) PT Raised to $400 at DA Davidson